A plant biotechnology approach leveraging karrikin (KAR) signaling through the KAI2 receptor to enhance salinity tolerance in major crops. Research shows KAI2 regulates ionic balance under salt stress, offering a pathway to develop salt-tolerant cotton, soybean, and maize varieties to address salinity-driven yield losses threatening global food security.
Soil salinity is a major abiotic stress that reduces crop yields and threatens global food security. This research program investigates how karrikin (KAR) signaling, mediated through the KARRIKIN INSENSITIVE2 (KAI2) receptor, promotes plant tolerance to salinity. Preliminary findings in Arabidopsis thaliana demonstrate that the kai2 mutant accumulates higher levels of Na+ and lower levels of essential ions such as K+, Mg2+, and Fe2+ under salt stress, resulting in greater physiological damage compared to wild-type plants. These results position KAI2 as a promising molecular target for biotechnological interventions aimed at improving salinity resilience in economically important crops such as cotton, maize, and soybean.
Key findings and features:
Planned research directions:
The technology is at an early discovery stage (TRL 1–2). Proof-of-concept data have been generated in Arabidopsis thaliana, demonstrating the role of KAI2 in salt tolerance. Future validation requires transcriptomic and metabolomic analyses, deeper mechanistic studies, and translational work in crop species. Collaboration with industry partners is sought to advance the research toward biotechnological applications and potential development of salt-tolerant crop varieties.
Texas Tech University is a large, comprehensive public research university in Lubbock and an anchor of the Texas Tech University System, coupling academic breadth with applied, collaborative research. Industry partners engage through a research park and incubator, co-located labs, shared core facilities, and West Texas field sites for pilot-scale and real-world testing. Proximity to the Permian Basin and regional manufacturing, plus collaboration with the system’s health sciences center, creates clear pathways for product development, clinical translation, and talent pipelines. Research is supported by competitive federal funding from agencies such as NSF, DOE, USDA, NIH, DoD, and NASA, and a dedicated technology transfer office streamlines IP, licensing, startup formation, and corporate contracting.